Diagnostic Specialty Antibody Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global diagnostic specialty antibody market looks promising with opportunities in hospitals and diagnostic laboratories. The global diagnostic specialty antibody market is expected to grow with a CAGR of 4%-6% from 2020 to 2025. The major drivers for this market are surge in government investment in diagnostic health care and increase in launch of new and innovative biologic diagnostic kits.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global diagnostic specialty antibody market report, please download the report brochure.
In this market, monoclonal antibodies is the fastest growing antibody type of diagnostic specialty antibody, whereas hospitals is the fastst growing end user. Growth in various segments of the diagnostic specialty antibody market are given below:
The study includes trends and forecast for the global diagnostic specialty antibodies market by antibody type, application, end user, and region as follows:
By Antibody Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Hepatitis Diagnosis
Tuberculosis Diagnostics
Dengue Diagnostics
Oncology Diagnostics
HIV Diagnostics
Infectious Disease Diagnostics
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Diagnostic Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
Spain
Italy
France
Asia Pacific
China
Japan
India
The Rest of the World
Brazil
Some of the diagnostic specialty antibodies companies profiled in this report include Abcam, Sanofi, Abbott laboratories, Hoffmann-La Roche, Danaher, Bio-Rad Laboratories, Boehringer Ingelheim International, Agilent Technologies, and Aytu BioScience.
Lucintel forecasts that monoclonal antibodies will remain the largest antibody type segment over the forecast period, as monoclonal antibodies play a vital role in the diagnosis of many infectious and chronic diseases, such as cancer. Also, an increase in the importance of monoclonal antibodies in scientific research for generation is projected to boost this segment over the forecast period.
Within this market, hospitals will remain the largest end user segment over the forecast period. Increase in the number of infectious diseases and rise in prevalence of cancer and HIV infections are likely to boost the segment during the forecast period.
North America will remain the largest region over the forecast period. Recent advancemants in diagnostic specialty antibody diagnostics, reimbursement for disease screening, and improved access to diagnostics are the major drivers of the diagnostic specialty antibody market in North America.
Features of the Global Diagnostic Specialty Antibody Market
Market Size Estimates: Global diagnostic specialty antibody market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global diagnostic specialty antibody market size by various segments, such as antibody type, application, and end user in terms of value.Regional Analysis: Global diagnostic specialty antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different antibody type, application, and end user, and region for the global diagnostic specialty antibody market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global diagnostic specialty antibody market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global diagnostic specialty antibody market by antibody type (monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies), application (hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, and infectious disease diagnostics), end user (hospitals and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global diagnostic specialty antibody market?
Q.5 What are the business risks and threats to the global diagnostic specialty antibody market?
Q.6 What are the emerging trends in this diagnostic specialty antibody market and the reasons behind them?
Q.7 What are some changing demands of customers in this diagnostic specialty antibody market?
Q.8 What are the new developments in this diagnostic specialty antibody market? Which companies are leading these developments?
Q.9 Who are the major players in this diagnostic specialty antibody market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this diagnostic specialty antibody market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global diagnostic specialty antibody market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies), Application (Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics), and End User (Hospitals and Diagnostic Laboratories)
Regional Scope North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global diagnostic specialty antibody market looks promising with opportunities in hospitals and diagnostic laboratories. The global diagnostic specialty antibody market is expected to grow with a CAGR of 4%-6% from 2020 to 2025. The major drivers for this market are surge in government investment in diagnostic health care and increase in launch of new and innovative biologic diagnostic kits.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global diagnostic specialty antibody market report, please download the report brochure.
In this market, monoclonal antibodies is the fastest growing antibody type of diagnostic specialty antibody, whereas hospitals is the fastst growing end user. Growth in various segments of the diagnostic specialty antibody market are given below:
The study includes trends and forecast for the global diagnostic specialty antibodies market by antibody type, application, end user, and region as follows:
By Antibody Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Hepatitis Diagnosis
Tuberculosis Diagnostics
Dengue Diagnostics
Oncology Diagnostics
HIV Diagnostics
Infectious Disease Diagnostics
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Diagnostic Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
Spain
Italy
France
Asia Pacific
China
Japan
India
The Rest of the World
Brazil
Some of the diagnostic specialty antibodies companies profiled in this report include Abcam, Sanofi, Abbott laboratories, Hoffmann-La Roche, Danaher, Bio-Rad Laboratories, Boehringer Ingelheim International, Agilent Technologies, and Aytu BioScience.
Lucintel forecasts that monoclonal antibodies will remain the largest antibody type segment over the forecast period, as monoclonal antibodies play a vital role in the diagnosis of many infectious and chronic diseases, such as cancer. Also, an increase in the importance of monoclonal antibodies in scientific research for generation is projected to boost this segment over the forecast period.
Within this market, hospitals will remain the largest end user segment over the forecast period. Increase in the number of infectious diseases and rise in prevalence of cancer and HIV infections are likely to boost the segment during the forecast period.
North America will remain the largest region over the forecast period. Recent advancemants in diagnostic specialty antibody diagnostics, reimbursement for disease screening, and improved access to diagnostics are the major drivers of the diagnostic specialty antibody market in North America.
Features of the Global Diagnostic Specialty Antibody Market
Market Size Estimates: Global diagnostic specialty antibody market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global diagnostic specialty antibody market size by various segments, such as antibody type, application, and end user in terms of value.Regional Analysis: Global diagnostic specialty antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different antibody type, application, and end user, and region for the global diagnostic specialty antibody market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global diagnostic specialty antibody market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global diagnostic specialty antibody market by antibody type (monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies), application (hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, and infectious disease diagnostics), end user (hospitals and diagnostic laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global diagnostic specialty antibody market?
Q.5 What are the business risks and threats to the global diagnostic specialty antibody market?
Q.6 What are the emerging trends in this diagnostic specialty antibody market and the reasons behind them?
Q.7 What are some changing demands of customers in this diagnostic specialty antibody market?
Q.8 What are the new developments in this diagnostic specialty antibody market? Which companies are leading these developments?
Q.9 Who are the major players in this diagnostic specialty antibody market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this diagnostic specialty antibody market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global diagnostic specialty antibody market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies), Application (Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics), and End User (Hospitals and Diagnostic Laboratories)
Regional Scope North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Diagnostic Specialty Antibody Market Trends and Forecast
3.3: Global Diagnostic Specialty Antibody Market by Antibody Type
3.3.1: Monoclonal Antibodies
3.3.2: Polyclonal Antibodies
3.3.3: Recombinant Polyclonal Antibodies
3.4: Global Diagnostic Specialty Antibody Market by Application
3.4.1: Hepatitis Diagnosis
3.4.2: Tuberculosis Diagnostics
3.4.3: Dengue Diagnostics
3.4.4: Oncology Diagnostics
3.4.5: HIV Diagnostics
3.4.6: Infectious Disease Diagnostics
3.5: Global Diagnostic Specialty Antibody Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Diagnostic Specialty Antibody Market by Region
4.2: North American Diagnostic Specialty Antibody Market
4.2.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.2.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.2.3: Market by End User: Hospitals and Diagnostic Laboratories
4.2.4: The United States Diagnostic Specialty Antibody Market
4.2.5: The Canadian Diagnostic Specialty Antibody Market
4.2.6: The Mexican Diagnostic Specialty Antibody Market
4.3: European Diagnostic Specialty Antibody Market
4.3.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.3.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.3.3: Market by End User: Hospitals and Diagnostic Laboratories
4.3.4: The German Diagnostic Specialty Antibody Market
4.3.5: The United Kingdom Diagnostic Specialty Antibody Market
4.3.6: The Spain Diagnostic Specialty Antibody Market
4.3.7: The Italy Diagnostic Specialty Antibody Market
4.3.8: The French Diagnostic Specialty Antibody Market
4.4: APAC Diagnostic Specialty Antibody Market
4.4.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.4.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.4.3: Market by End User: Hospitals and Diagnostic Laboratories
4.4.4: The Chinese Diagnostic Specialty Antibody Market
4.4.5: The Indian Diagnostic Specialty Antibody Market
4.4.6: The Japanese Diagnostic Specialty Antibody Market
4.5: ROW Diagnostic Specialty Antibody Market
4.5.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.5.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.5.3: Market by End User: Hospitals and Diagnostic Laboratories
4.5.4: Brazilian Diagnostic Specialty Antibody Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Antibody Type
7.1.2: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Application
7.1.3: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by End User
7.1.4: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Region
7.2: Emerging Trends in the Global Diagnostic Specialty Antibody Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Diagnostic Specialty Antibody Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Specialty Antibody Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abcam plc
8.2: Sanofi
8.3: Abbott Laboratories
8.4: Hoffmann-La Roche Ltd
8.5: Danaher Corporation
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Diagnostic Specialty Antibody Market Trends and Forecast
3.3: Global Diagnostic Specialty Antibody Market by Antibody Type
3.3.1: Monoclonal Antibodies
3.3.2: Polyclonal Antibodies
3.3.3: Recombinant Polyclonal Antibodies
3.4: Global Diagnostic Specialty Antibody Market by Application
3.4.1: Hepatitis Diagnosis
3.4.2: Tuberculosis Diagnostics
3.4.3: Dengue Diagnostics
3.4.4: Oncology Diagnostics
3.4.5: HIV Diagnostics
3.4.6: Infectious Disease Diagnostics
3.5: Global Diagnostic Specialty Antibody Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Laboratories
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Diagnostic Specialty Antibody Market by Region
4.2: North American Diagnostic Specialty Antibody Market
4.2.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.2.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.2.3: Market by End User: Hospitals and Diagnostic Laboratories
4.2.4: The United States Diagnostic Specialty Antibody Market
4.2.5: The Canadian Diagnostic Specialty Antibody Market
4.2.6: The Mexican Diagnostic Specialty Antibody Market
4.3: European Diagnostic Specialty Antibody Market
4.3.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.3.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.3.3: Market by End User: Hospitals and Diagnostic Laboratories
4.3.4: The German Diagnostic Specialty Antibody Market
4.3.5: The United Kingdom Diagnostic Specialty Antibody Market
4.3.6: The Spain Diagnostic Specialty Antibody Market
4.3.7: The Italy Diagnostic Specialty Antibody Market
4.3.8: The French Diagnostic Specialty Antibody Market
4.4: APAC Diagnostic Specialty Antibody Market
4.4.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.4.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.4.3: Market by End User: Hospitals and Diagnostic Laboratories
4.4.4: The Chinese Diagnostic Specialty Antibody Market
4.4.5: The Indian Diagnostic Specialty Antibody Market
4.4.6: The Japanese Diagnostic Specialty Antibody Market
4.5: ROW Diagnostic Specialty Antibody Market
4.5.1: Market by Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies
4.5.2: Market by Application: Hepatitis Diagnosis, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, and Infectious Disease Diagnostics
4.5.3: Market by End User: Hospitals and Diagnostic Laboratories
4.5.4: Brazilian Diagnostic Specialty Antibody Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Antibody Type
7.1.2: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Application
7.1.3: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by End User
7.1.4: Growth Opportunities for the Global Diagnostic Specialty Antibody Market by Region
7.2: Emerging Trends in the Global Diagnostic Specialty Antibody Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Diagnostic Specialty Antibody Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Specialty Antibody Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Abcam plc
8.2: Sanofi
8.3: Abbott Laboratories
8.4: Hoffmann-La Roche Ltd
8.5: Danaher Corporation
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
